Erika B-Cure Laser Ltd
BCUR.TA
Tel Aviv Stock Exchange16.80
ILA
+0.50
- -
Erika B-Cure Laser Ltd
BCUR.TA
(Tel Aviv Stock Exchange)
Recent
price
16.80
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Erika B-Cure Laser Ltd operates as a developer, manufacturer, marketer, and distributor of specialized laser products, reaching customers both in Israel and across international markets. The company provides a range of B-Cure Laser devices, which leverage low-level laser therapy (LLLT) technology, also known as photobiomodulation, for diverse therapeutic applications. Its product lineup includes the B-Cure Laser Classic, a home-use medical solution addressing pain, various orthopedic conditions, skin issues, inflammation, and assisting in wound recovery. Another offering is the B-Cure Laser Pro, a more potent device designed for managing acute and chronic ailments, such as complex orthopedic problems, diabetic wounds, and difficulties in healing and mucositis, suitable for both professional and personal environments. Additionally, the company features specialized units like the B-Cure Laser Sport, engineered for at-home treatment of sports-related injuries and muscle discomfort, alongside its enhanced version, the B-Cure Laser Sport Pro, a professional instrument for intense sports injuries and broad pain management, including conditions like Achilles tendonitis. For dental care, the B-Cure Laser Dental series provides tools for clinical settings, alleviating gum pain, combating inflammation, and promoting faster healing after procedures such as implants. Established in 2007 and headquartered in Haifa, Israel, the company was rebranded to Erika B-Cure Laser Ltd in January 2022 from its former name, Erica Carmel Ltd. The B-Cure Laser products are recognized as Class 2 medical devices, holding certifications such as CE 0197, Health Canada clearance, and ANVISA approval, demonstrating their clinically proven efficacy and safety for a wide user base.